Risk Factors For Developing Avascular Necrosis Or Fractures In Patients With Type 1 Gaucher Disease: Analysis From The Gaucher Registry

被引：1
|
作者：
Khan, Aneal [1 ]
Hangartner, Thomas [2 ]
Weinreb, Neal [3 ]
Taylor, John [4 ]
Mistry, Pramod [5 ]
机构：
[1] Univ Calgary, Alberta Childrens Hosp, Calgary, AB, Canada
[2] Wright State Univ, Dayton, OH 45435 USA
[3] Univ Fdn Lysosomal Storage Disorders, Coral Springs, FL USA
[4] Genzyme, Cambridge, MA USA
[5] Yale Univ, Sch Med, New Haven, CT USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2012年 / 105卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2011.11.091
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [31] Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: An analysis of 798 patients from the ICGG Gaucher Registry
    Fairley, C.
    Zimran, A.
    Phillips, M.
    Cizmarik, M.
    Yee, J.
    Weinreb, N.
    Packman, S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 (06) : 738 - 744
  • [32] Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment
    Weinreb, Neal J.
    Camelo, Jose Simon, Jr.
    Charrow, Joel
    McClain, Monica R.
    Mistry, Pramod
    Belmatoug, Nadia
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : 100 - 111
  • [33] Characteristics of 27 patients with type 3 Gaucher disease: a descriptive analysis from the Gaucher Outcome Survey
    Schwartz, Ida Vanessa D.
    Goker-Alpan, Ozlem
    Kishnani, Priya
    Zimran, Ari
    Renault, Lydie
    Panahloo, Zoya
    Deegan, Patrick
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S120 - S121
  • [34] Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey
    Schwartz, Ida Vanessa D.
    Goker-Alpan, Ozlem
    Kishnani, Priya S.
    Zimran, Ari
    Renault, Lydie
    Panahloo, Zoya
    Deegan, Patrick
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2018, 14 : 73 - 79
  • [35] An Analysis from the ICGG Gaucher Registry: A Report of Gaucher Patients Affected by Reduced Doses of Imiglucerase
    Cole, Alexander
    Weinreb, Neal
    Rosenbloom, Barry
    Andersson, Hans
    Tripuraneni, Radhika
    Belmatoug, Nadia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S69 - S69
  • [36] Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis
    Mistry, Pramod K.
    Deegan, Patrick
    Vellodi, Ashok
    Cole, J. Alexander
    Yeh, Michael
    Weinreb, Neal J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (04) : 561 - 570
  • [37] The risk of Parkinson's disease in type 1 Gaucher disease
    Bultron, Gilberto
    Kacena, Katherine
    Pearson, Daniel
    Boxer, Michael
    Yang, Ruhua
    Sathe, Swati
    Pastores, Gregory
    Mistry, Pramod K.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (02) : 167 - 173
  • [38] Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: A report from the Gaucher Registry
    Weinreb, NJ
    Charrow, J
    Andersson, HC
    Kaplan, P
    Kolodny, EH
    Mistry, P
    Pastores, G
    Rosenbloom, BE
    Scott, CR
    Wappner, RS
    Zimran, A
    AMERICAN JOURNAL OF MEDICINE, 2002, 113 (02): : 112 - 119
  • [39] Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry
    Cappellini, Maria Domenica
    Carubbi, Francesca
    Di Rocco, Maja
    Giona, Fiorina
    Giuffrida, Gaetano
    BLOOD CELLS MOLECULES AND DISEASES, 2023, 98
  • [40] Phenotypic Spectrum of Hematological and Visceral Disease in Type 3 Gaucher Disease and Response to Imiglucerase Therapy: Preliminary Analysis from the ICGG Gaucher Registry
    Cole, J. Alexander
    Mistry, Pramod
    Kolodny, Edwin H.
    Tylki-Szymanska, Anna
    Belmatoug, Nadia
    Cabello, Juan F.
    Vellodi, Ashok
    Grabowski, Gregory
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 154 - 154
12345